October 13, 2025

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 6.84% Potential Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the ophthalmic industry, has long been a beacon for innovation in eye health. With a market capitalization of $5.08 billion, the..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 32% Upside Potential with Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is capturing investor attention due to its promising drug pipeline and notable upside potential. With a focused approach..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: A Biotech Powerhouse with 17% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a compelling player in the biotechnology sector, specializing in the treatment of rare neuroendocrine diseases. With its lead product, IMCIVREE (setmelanotide), Rhythm is making..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating the Healthcare Tech Landscape with a 29% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company headquartered in New York, is garnering attention in the healthcare sector with its innovative approach to health plans and technology solutions...

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a Potential 99.86% Upside in the Biotech Space

ADMA Biologics Inc. (NASDAQ: ADMA), a prominent player in the biotechnology sector, has been capturing investor attention with its promising market position and growth potential. The company is committed to..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A 38% Upside Potential with Robust Analyst Support

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, has been attracting considerable attention from investors due to its significant growth potential and strong pipeline of pharmaceutical..

Prestige Consumer Healthcare (PBH) Stock Analysis: Unveiling a Potential 35% Upside for Investors

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a prominent player in the healthcare sector, specifically within the drug manufacturing industry, focusing on over-the-counter (OTC) health and personal care products...

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Growth, Innovation, and a Strategic Pipeline Fueling Investor Interest

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, has been making waves with its innovative RNA-targeted medicines. With a market capitalization of $11.15 billion and a..

Smith & Nephew (SNN) Stock Analysis: Exploring Growth Amidst a Solid 6.61% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands as a formidable player in the healthcare sector, specifically in the medical devices industry. Headquartered in Watford, United Kingdom, the company boasts..

Legend Biotech Corporation (LEGN) Investor Outlook: Unpacking a 140.9% Potential Upside Amidst a Robust Oncology Pipeline

Legend Biotech Corporation (NASDAQ: LEGN) is capturing investor attention with a remarkable 140.9% potential upside, anchored by its innovative strides in the biotechnology sector. As a leading player in the..

Telix Pharmaceuticals Limited (TLX) Investor Outlook: Unveiling a 117.90% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biotechnology industry, has been making waves with its innovative approach to radiopharmaceuticals. With its market capitalization standing at $3.31 billion,..

Doximity, Inc. (DOCS) Stock Analysis: Understanding the 6.86% Potential Upside for Investors

Doximity, Inc. (DOCS), a leader in the health information services sector, has carved out a unique niche in the digital healthcare landscape. With a market capitalization of $12.29 billion, Doximity..

BrightSpring Health Services (BTSG) Stock Analysis: A 5.54% Upside Amid Robust Revenue Growth

BrightSpring Health Services, Inc. (NASDAQ: BTSG) is capturing investor attention with its impressive revenue growth of 29.10% and a potential upside of 5.54% based on the average target price from..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Exploring a 29% Upside in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company based in Morrisville, North Carolina, is making waves in the healthcare sector with a promising growth trajectory. The company’s primary focus on..

Revolution Medicines (RVMD) Stock Analysis: Unveiling a 56% Potential Upside Amidst Robust Buy Ratings

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing investor attention in the biotechnology space with its promising portfolio of targeted therapies for RAS-addicted cancers. As a clinical-stage precision oncology company, Revolution..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Volatility with a 65% Potential Upside

Moderna, Inc. (NASDAQ: MRNA) remains a prominent player in the biotechnology sector, primarily recognized for its transformative messenger RNA (mRNA) medicines. With a current market capitalization of $10.44 billion, the..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unlocking Potential with a 19.51% Upside and Revolutionary Biotech Ventures

BridgeBio Pharma, Inc. (BBIO), a prominent player in the biotechnology sector, has been generating significant interest among investors due to its robust pipeline of transformative medicines and a compelling 19.51%..

STERIS plc (STE) Stock Analysis: Exploring a 15.50% Potential Upside in the Healthcare Sector

Investors eyeing the healthcare sector should take a closer look at STERIS plc (NYSE: STE), a leading provider of infection prevention products and services. With a market capitalization of $23.23..

Exact Sciences Corporation (EXAS) Stock Analysis: Exploring a 14.46% Potential Upside in the Healthcare Sector

Exact Sciences Corporation (NASDAQ: EXAS) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $11.04 billion, the company stands..

Ascendis Pharma A/S (ASND)

⚠️ No article content returned.

..
Search

Funds

October 13, 2025

Search

Funds

October 13, 2025

FTSE 100

Funds